UHLMANN PRICE SECURITIES’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
SLAM
CWP
UHLMANN PRICE SECURITIES's PFE Position: Q2 2026 in Review
UHLMANN PRICE SECURITIES increased its Pfizer (PFE) stake by 6.4% in Q2 2026, buying an estimated $59.2K and bringing the position to 37,865 shares worth $912K. The position accounts for 0.03% of the portfolio, ranked #85.
UHLMANN PRICE SECURITIES first reported a position in PFE in Q3 2024 and has held it in 8 quarters since. The position peaked at $976K in Q1 2026. 1,257 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- UHLMANN PRICE SECURITIES held 37,865 shares of Pfizer worth $912K as of Q2 2026.
- UHLMANN PRICE SECURITIES bought 2,263 Pfizer shares in Q2 2026, an estimated $59.2K.
- Pfizer made up 0.03% of UHLMANN PRICE SECURITIES's portfolio in Q2 2026, its #85 holding.
- UHLMANN PRICE SECURITIES first reported a position in Pfizer in Q3 2024 and has held it in 8 quarters since.
- UHLMANN PRICE SECURITIES's Pfizer position peaked at $976K in Q1 2026.
- 1,257 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on UHLMANN PRICE SECURITIES's 13F filing for Q2 2026, filed 24 Jul 2026.